Latest Nucleosides Stories
Celgene has announced that Vidaza has received expanded FDA approval to reflect new overall survival achieved in the AZA-001 survival study of patients with higher-risk myelodysplastic syndromes.
The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is pleased to inform patients that the U.S.
Clinical Data, Inc. (NASDAQ:CLDA) today announced the acquisition of Adenosine Therapeutics, L.L.C., a developer of drug products based on its extensive portfolio of composition of matter and method of use patents relating to selective adenosine receptor modulators.
NEW YORK, July 28 /PRNewswire/ -- AIM Pharmakon, Inc. (API), a New York-based company, announced today the introduction of the next generation of high-level cardiovascular health and longevity products starting with Aim Endurance(TM), a new premium quality liquid concentrate.
BOULDER, Colo., and KYOTO, Japan, Nov. 21 /PRNewswire-FirstCall/ -- Pharmion Corporation and Nippon Shinyaku Co., Ltd today announced the completion of an exclusive license agreement for development and commercialization rights to Vidaza (azacitidine for injectable suspension) in Japan.
- A coin originally worth six pennies Scots, and later three; held equivalent to an English halfpenny.
- (in plural) Money; cash.